Arcus Biosciences RCUS
NYSE RCUS
$19.04 -4.71 (-19.83%)
As of: Oct 21, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) Long-Term Debt Issuances (2024)

Updated

Arcus Biosciences (RCUS) reported Long-Term Debt Issuances of $49 million for FY2025, up 4.3% from $47 million in FY2024.

Analysis

Arcus Biosciences (RCUS) Long-Term Debt Issuances (2024) Analysis & Trends

  • According to Business Quant data, Long-Term Debt Issuances came in at $47 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Arcus Biosciences 2.42 Bn -911.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 47.00 Mn
API Access

Arcus Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=RCUS&period=max&api_key=YOUR_API_KEY